R
OCKVILLE, Md.--Celera Genomics and City of Hope Cancer Center of Duarte, Calif., have decided to work together to investigate associations of genetic polymorphisms with breast cancer. Celera retains the rights to use all information generated from the collaboration in its database products, and all intellectual property developed through the joint effort will be owned equally by Celera and City of Hope.
The collaboration combines City of Hope’s pioneering clinical genetics approach with Celera’s DNA sequence information and polymorphism information databases. City of Hope has developed expertise in establishing the genetic basis of disease and Celera has assembled one of the largest sequence databases.
